clodronic acid has been researched along with Jaw Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Halling, F; Lux, C; Otto, M; Schlittenbauer, T; Ziebart, T | 1 |
| McCaul, JA | 1 |
| Ekanayake, K; Omer, O; Polyzois, I; Rice, N; Stassen, LF | 1 |
| Alons, K; de Jong, E; Kuijpers, SC; van Merkesteyn, JP | 1 |
| Bauss, F; Drosse, I; Ehrenfeld, M; Opelz, C; Otto, S; Pautke, C; Schieker, M; Schwager, J; Westphal, I | 1 |
| Erskine, JG; McQuaker, IG; Montazeri, AH | 1 |
| Colella, G; Guida, L; Pozzuoli, G | 1 |
2 review(s) available for clodronic acid and Jaw Diseases
| Article | Year |
|---|---|
Pharmacologic modalities in the treatment of osteoradionecrosis of the jaw.
Topics: Anti-Bacterial Agents; Antioxidants; Bone Density Conservation Agents; Chemoradiotherapy; Clodronic Acid; Combined Modality Therapy; Humans; Hyperbaric Oxygenation; Jaw Diseases; Orthognathic Surgical Procedures; Osteoradionecrosis; Pentoxifylline; Plastic Surgery Procedures; Radiation-Protective Agents; Tocopherols | 2014 |
The management of osteoradionecrosis of the jaws--a review.
Topics: Algorithms; Anti-Inflammatory Agents; Clodronic Acid; Fibrosis; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Jaw Diseases; Osteoradionecrosis; Pentoxifylline; Radiation-Protective Agents; Radiotherapy; Tocopherols | 2015 |
5 other study(ies) available for clodronic acid and Jaw Diseases
| Article | Year |
|---|---|
Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.
Topics: Acyclic Monoterpenes; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Endothelial Cells; Humans; Ibandronic Acid; Jaw Diseases; Mouth Diseases; Osteonecrosis; Wound Healing; Zoledronic Acid | 2022 |
Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Chronic Disease; Clinical Protocols; Clodronic Acid; Debridement; Dental Implants; Diphosphonates; Female; Humans; Injections, Intravenous; Jaw Diseases; Middle Aged; Osteomyelitis; Osteonecrosis; Pamidronate; Retrospective Studies; Tooth Extraction | 2009 |
Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Topics: Bone Density Conservation Agents; Cell Line; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Clodronic Acid; Diphosphonates; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Ibandronic Acid; Imidazoles; Jaw Diseases; Mesenchymal Stem Cells; Osteonecrosis; Time Factors; Zoledronic Acid | 2010 |
Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
Topics: Adult; Clodronic Acid; Humans; Jaw Diseases; Male; Multiple Myeloma; Osteonecrosis | 2007 |
[The involvement of the oromaxillofacial area in secondary hyperparathyroidism].
Topics: Chronic Disease; Clodronic Acid; Combined Modality Therapy; Face; Female; Humans; Hyperparathyroidism, Secondary; Jaw Diseases; Middle Aged; Mouth Diseases; Parathyroidectomy | 1990 |